56 results on '"van Gulik T"'
Search Results
2. Relief of Symptoms and Quality of Life after Conservative versus Surgical Treatment of Benign Liver Tumors (CONSULT): A Retrospective Propensity Score Matched Study
3. Surgical Morbidity in the First Year after Resection for Perihilar Cholangiocarcinoma
4. Results from the European Survey on Preoperative Management and Optimization Protocols for PeriHilar Cholangiocarcinoma (PHC)
5. Results from the European survey on preoperative management and optimization protocols for perihilar cholangiocarcinoma (PHC)
6. Primary and secondary liver failure after major liver resection for perihilar cholangiocarcinoma
7. Hypertrophy responses after portal vein embolization, complete and partial ALPPS in patients undergoing major liver resection
8. Functional and volumetric assessment of postoperative liver regeneration after major liver resection
9. Choledochal malformations in adult patients: Results from a national registry in a Western population
10. A methodological review of clinical outcomes reported in Liver Transplantation cholangiocarcinoma
11. Does jaundice preclude resection in gallbladder cancer?
12. Selective concomitant portal vein resection for perihilar cholangiocarcinoma
13. Transarterial (chemo-)embolization and lipiodolization for hepatic haemangioma
14. External validation of the international standardized grades of severity and outcome for bile duct injury
15. Initial analysis of the Dutch national hepatobiliary audit; the volume-outcome association
16. Hepatic microvascular changes after reversible versus permanent portal vein embolization in rabbits
17. Morbidity and mortality following major liver resection in patients with perihilar cholangiocarcinoma: A systematic review and meta-analysis
18. Comparison of short- and long-term outcomes between anatomical subtypes of resected biliary tract cancer in a Western high-volume center
19. Implementation and outcomes of a national liver surgeons expert panel to determine secondary resectability in patients with initially unresectable colorectal liver metastases (CRLM)
20. Treatment of mid-bile duct cholangiocarcinoma: Local resection or pancreatoduodenectomy?
21. Expression of integrin a?β6 to differentiate perihilar cholangiocarcinoma from benign disease: A pilot study.
22. Trends in incidence, treatment and survival of gallbladder cancer; a nation-wide cohort study
23. Post cholecystectomy bile duct injury: early, intermediate or late repair with hepaticojejunostomy – an E-AHPBA multi-center study
24. Stress test of liver function using 99mTc-mebrofenin Hepatobiliary Scintigraphy (HBS)
25. REsect: Blinded assessment of resectability of previously unresectable colorectal cancer liver metastases following chemotherapy±Y90-RadioEmbolization
26. IgG4-associated cholangitis mimicking perihilar cholangiocarcinoma; a persistent dilemma
27. Assessment of colorectal liver metastasis: results of the Dutch Colorectal Cancer Group (DCCG) liver metastases expert panel of the CAIRO5 study
28. Assessment of colorectal liver metastasis: results of the Dutch Colorectal Cancer Group (DCCG) liver metastases expert panel of the CAIRO5 study
29. Stress test of liver function using 99mTc-mebrofenin Hepatobiliary Scintigraphy (HBS)
30. IgG4-associated cholangitis mimicking perihilar cholangiocarcinoma; a persistent dilemma
31. Preoperative endoscopic versus percutaneous transhepatic biliary drainage in resectable perihilar cholangiocarcinoma: a randomized controlled trial
32. REsect: blinded assessment of resectability of previously unresectable colorectal cancer liver metastases following chemotherapy±Y90-RadioEmbolization
33. Preoperative endoscopic versus percutaneous transhepatic biliary drainage in resectable perihilar cholangiocarcinoma: a randomized controlled trial
34. Preoperative prognostic model to predict surgical success in patients with perihilar cholangiocarcinoma
35. Functional and volumetric response of liver segment 4 after right portal vein embolization
36. A comparison of treatment and outcomes of perihilar cholangiocarcinoma in an eastern and western center
37. The measured hepatic function increase after portal vein embolization measured by 99mTc-mebrofenin hepatobiliary scintigraphy is not attributed by an increased microvascular blood flow
38. Assessment of Liver parenchymal quality in patients with hepatocellular carcinoma using functional hepatobiliary scintigraphy and transient elastography
39. Short- and long-term outcomes in 1438 consecutive pancreatoduodenectomies: a single-center 25-years' experience
40. Who should not undergo alpps for colorectal liver metastases?
41. Preoperative biliary drainage reverses cholestasis-associated inflammatory and fibrotic gene signatures in patients with perihilar cholangiocarcinoma
42. Survival after resection of perihilar cholangiocarcinoma in patients with lymph node metastases
43. Conditional probability of long-term survival in patients with locally advanced and metastatic hilar cholangiocarcinoma
44. Time-dependent impact of irreversible electroporation on pancreas, liver, blood vessels and nerves: a systematic review of experimental studies
45. Conditional probability of long-term survival in patients with locally advanced and metastatic hilar cholangiocarcinoma
46. The prognostic value of hepatic artery and portal vein involvement in patients with perihilar cholangiocarcinoma
47. Referral of patients with suspicion of perihilar cholangiocarcinoma to a tertiary center: A retrospective audit following introduction of a national management guideline
48. Learning curve in laparoscopic liver resection: Single center consecutive cohort
49. Development of a risk score to predict occult metastatic or locally advanced disease in patients with resectable perihilar cholangiocarcinoma
50. Staging laparoscopy for detecting unresectable disease in patients with potentially resectable perihilar cholangiocarcinoma: A systematic review and meta-analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.